M. Dalla Palma

Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis

V. Zagonel, G. Lombardi, P. Fiduccia, 2012, Cancer Chemotherapy and Pharmacology.

Overall survival in BRCA-associated ovarian cancer: case-control study of an Italian series.

S. Mocellin, L. Borgato, G. Artioli, 2010, European Journal of Gynaecological Oncology.

An update on targeted therapy in metastatic renal cell carcinoma.

G. Lombardi, D. Pastorelli, F. Zustovich, 2012, Urologic oncology.

Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.

L. Chieco‐Bianchi, M. Montagna, S. Agata, 2003, Human Molecular Genetics.

Large genomic deletions inactivate the BRCA2 gene in breast cancer families

L. Chieco‐Bianchi, S. Agata, G. Zavagno, 2005, Journal of Medical Genetics.

Bevacizumab and glioblastomas, a single-centre experience: how disease history and characteristics may affect clinical outcome.

V. Zagonel, R. Manara, G. Lombardi, 2010, Anticancer research.

Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.

M. Vidal, M. Cusick, Q. Zhong, 2009, Cancer research.

PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.

V. Zagonel, M. Gregianin, L. Evangelista, 2012, Critical reviews in oncology/hematology.